Evidence map›Paper›PMID 38644967›Full record

ArticleACS nanoscience Au2024

Single-Molecule Investigation of the Binding Interface Stability of SARS-CoV-2 Variants with ACE2.

Ankita Ray, Thu Thi Minh Tran, Rita Dos Santos Natividade, Rodrigo A Moreira, Joshua D Simpson, Danahe Mohammed, Melanie Koehler, Simon J L Petitjean, Qingrong Zhang, Fabrice Bureau and 3 more

Open access · goldAbstract read
In one paragraph

Article in ACS nanoscience Au, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Ankita RayLouvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID https://orcid.org/0000-0002-5059-9598
Thu Thi Minh TranFaculty of Materials Science and Technology, University of Science-VNU HCM, 227 Nguyen Van Cu Street, District 5, 700000 Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0000-0001-8357-8462
Rita Dos Santos NatividadeLouvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID https://orcid.org/0000-0002-0123-4760
Rodrigo A MoreiraBasque Center for Applied Mathematics, Mazarredo 14, 48009 Bilbao, Spain.
Joshua D SimpsonLouvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID https://orcid.org/0000-0002-8823-8130
Danahe MohammedLouvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.
Melanie KoehlerLouvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.
Simon J L PetitjeanLouvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.
Qingrong ZhangLouvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.
Fabrice BureauLaboratory of Cellular and Molecular Immunology, GIGA Institute, Liège University, 4000 Liège, Belgium.
Laurent GilletImmunology-Vaccinology Lab of the Faculty of Veterinary Medicine, Liège University, 4000 Liège, Belgium.
Adolfo B PomaInstitute of Fundamental Technological Research, Polish Academy of Sciences, Pawińskiego 5B, 02-106 Warsaw, Poland.ORCID https://orcid.org/0000-0002-8875-3220
David AlsteensLouvain Institute of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium.ORCID https://orcid.org/0000-0001-9229-113X
UCLouvain · BEUniversity of Liège · BEBasque Center for Applied Mathematics · ESInstitute of Fundamental Technological Research · PLVietnam National University Ho Chi Minh City · VNWalloon Excellence in Lifesciences and Biotechnology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 pandemic spurred numerous research endeavors to comprehend the virus and mitigate its global severity. Understanding the binding interface between the virus and human receptors is pivotal to these efforts and paramount to curbing infection and transmission. Here we employ atomic force microscopy and steered molecular dynamics simulation to explore SARS-CoV-2 receptor binding domain (RBD) variants and angiotensin-converting enzyme 2 (ACE2), examining the impact of mutations at key residues upon binding affinity. Our results show that the Omicron and Delta variants possess strengthened binding affinity in comparison to the Mu variant. Further, using sera from individuals either vaccinated or with acquired immunity following Delta strain infection, we assess the impact of immunity upon variant RBD/ACE2 complex formation. Single-molecule force spectroscopy analysis suggests that vaccination before infection may provide stronger protection across variants. These results underscore the need to monitor antigenic changes in order to continue developing innovative and effective SARS-CoV-2 abrogation strategies.

Identifiers

PMID38644967
PMCPMC11027127
OpenAlexW4392619325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.